QR код

The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancer

T-cell recruiting chemokines are required for a successful immune intervention in ovarian cancer, and also for the efficacy of modern anticancer agents such as PARP inhibitors. The chemokine CX3CL1 recruits tumour-suppressive T-cells into solid tumours, but also mediates cell–cell adhesions, e.g. of...

Повний опис

Збережено в:
Автори: Stefanie Seitz, Tobias F. Dreyer, Christoph Stange, Katja Steiger, Dirk Wohlleber, Martina Anton, Thuý An Pham, Dominique Sauter-Peschke, Ute Reuning, Gabriele Multhoff, Wilko Weichert, Marion Kiechle, Viktor Magdolen, Holger Bronger
Формат: Artigo
Мова:Inglês
Опубліковано: Elsevier 2025-02-01
Серія:Neoplasia: An International Journal for Oncology Research
Предмети:
Chemokines
CX3CL1
Tumour-infiltrating lymphocytes
PARP inhibition
Mouse model
Онлайн доступ:http://www.sciencedirect.com/science/article/pii/S1476558625000090
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси